Biblio Discovery — Demo Discovery Service

4 results for "Liu, Che-Yu"

Showing 1–4 · 0.28 seconds · RSS

  1. Journal Article Full text

    Study on Tripping Risks in Fast Walking through Cadence-Controlled Gait Analysis

    Wang, Wen-Fong; Lien, Wei-Chih; Liu, Che-Yu et al.

    J Healthc Eng · 2018 · English · PubMed Central

    Fast walking is a common exercise for most people to promote health. However, a higher cadence due to fast walking on ordinary or uneven ground raises the risk of tripping. To investigate the tripping issue, research to observe the gait in fast walking is needed. To explore the relationship between…

  2. Journal Article Full text

    Downregulation of VEGFR2 signaling by cedrol abrogates VEGF‑driven angiogenesis and proliferation of glioblastoma cells through AKT/P70S6K and MAPK/ERK1/2 pathways

    Chang, Kai-Fu; Liu, Che-Yu; Huang, Ya-Chih et al.

    Oncol Lett · 2023 · English · PubMed Central

    Cedrol is a sesquiterpene alcohol isolated from Cedrus atlantica, which has been traditionally used in aromatherapy and has anticancer, antibacterial and antihyperalgesic effects. One characteristic of glioblastoma (GB) is the overexpression of vascular endothelial growth factor (VEGF), which…

  3. Journal Article Full text

    GaN Micromechanical Resonators with Meshed Metal Bottom Electrode

    Ansari, Azadeh; Liu, Che-Yu; Lin, Chien-Chung et al.

    Materials (Basel) · 2015 · English · PubMed Central

    This work describes a novel architecture to realize high-performance gallium nitride (GaN) bulk acoustic wave (BAW) resonators. The method is based on the growth of a thick GaN layer on a metal electrode grid. The fabrication process starts with the growth of a thin GaN buffer layer on a Si (111)…

  4. Journal Article Full text

    Mortality Evaluation and Life Expectancy Prediction of Patients with Hepatocellular Carcinoma with Data Mining

    Liu, Che-Yu; Cheng, Chen-Yang; Yang, Szu-Ying et al.

    Healthcare (Basel) · 2023 · English · PubMed Central

    Background: The complexity of systemic variables and comorbidities makes it difficult to determine the best treatment for patients with hepatocellular carcinoma (HCC). It is impossible to perform a multidimensional evaluation of every patient, but the development of guidelines based on analyses of…